The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Amgen; Biomarin
Consulting or Advisory Role - Aduro Biotech; Aminex; Arch Oncology; Crown Bioscience; CytomX Therapeutics; Grace Science; Myovant Sciences; Plexxikon; Prothena; Rhizen Pharmaceuticals; Shanghai Pharma; Sunesis Pharmaceuticals; Upsher-Smith; Your Encore [Pfizer, Amgen]
Patents, Royalties, Other Intellectual Property - Tularik/Amgen; Upsher-Smith
Expert Testimony - Puma Biotechnology
Safety and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma.
 
William Bensinger
Honoraria - Acetylon Pharmaceuticals; Amgen; Celgene
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Merck; Sanofi
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Acetylon Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celgene; Karyopharm Therapeutics; Merck; Sanofi
Expert Testimony - Celgene; Takeda
 
Anastasios Raptis
Stock and Other Ownership Interests - Allergan; Bayer; Celgene; Cerecor; Contrafect; Dermira; Hypera S.A; Johnson & Johnson; Lannett; Merck; Mylan; Novartis; Pfizer; Roche; TetraLogic Pharmaceuticals; Teva
 
James R. Berenson
Employment - OncoTracker
Leadership - OncoTracker
Stock and Other Ownership Interests - OncoTracker
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Aduro Biotech; Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Takeda
Speakers' Bureau - Amgen; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Aduro Biotech; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Patents, Royalties, Other Intellectual Property - OncoTracker
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Celgene; Janssen; Takeda
 
Alexander I. Spira
Honoraria - AstraZeneca/MedImmune; CytomX Therapeutics; Merck
Consulting or Advisory Role - Array BioPharma (Inst)
Research Funding - Abbvie (Inst); Archer (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Ignyta (Inst); Incyte (Inst); LAM Therapeutics; LAM Therapeutics (Inst); Loxo (Inst); Macrogenics (Inst); MedImmune (Inst); Newlink Genetics (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst); Trovagene (Inst)
 
Ajay K. Nooka
Consulting or Advisory Role - Adaptive technologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Spectrum Pharmaceuticals; Takeda
 
Maria Chaudhry
No Relationships to Disclose
 
Peter van Zandvoort
Employment - Aduro Biotech
 
Nitya Nair
Employment - Aduro Biotech
Stock and Other Ownership Interests - Aduro Biotech
Patents, Royalties, Other Intellectual Property - Stanford University School of Medicine
 
Jeannette Lo
Employment - Aduro Biotech
Travel, Accommodations, Expenses - Aduro Biotech
 
Jeroen Elassaiss-Schaap
Employment - PD-value
Stock and Other Ownership Interests - PD-value
Consulting or Advisory Role - PD-value
 
Jackie Walling
No Relationships to Disclose
 
Parameswaran Hari
Honoraria - Amgen; Celgene; Juno Therapeutics; Novartis; Sanofi; Spectrum Pharmaceuticals
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite, a Gilead company; Sanofi; Spectrum Pharmaceuticals; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)